Patient Characteristics and Treatment Patterns for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) By CAR T Eligibility and Treatment Status in France, Germany, Italy, Spain, the UK, and Japan
Year: 2024
Type: conference-abstract
Source: Blood
Authors: Andrew Park, Selin Cooper, Sheila Mpima, Vicky Casey, Moulika Chatu, Ângela Nunes, Fil Manuguid, Alexander Liede
Institutions: AbbVie (United States), IQVIA (United Kingdom)
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4405039489